Sector revisions Pharmaron Beijing Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
31.94 ^CNY	-2.56%		+1.11%	+12.35%

Jan. 14	Pharmaron Beijing to place 58.4 million new H shares at RMB1.00 per share	RE
Jan. 14	Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	PHARMARON BEIJING CO., LTD.							11
	LONZA GROUP AG							23
	IQVIA HOLDINGS INC.							20
	BEONE MEDICINES AG							24
	CELLTRION, INC.							22
	REVOLUTION MEDICINES, INC.							19
	MEDPACE HOLDINGS, INC.							12
	EUROFINS SCIENTIFIC SE							15
	ICON PUBLIC LIMITED COMPANY							16
	ASCENDIS PHARMA A/S							15
	TEMPUS AI, INC.							12
	IONIS PHARMACEUTICALS, INC.							22
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.							14
	BIO-TECHNE CORPORATION							12
	QIAGEN N.V.							13
	Average							17
	Weighted average by Cap.							19